Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.
about
DNA gyrase, topoisomerase IV, and the 4-quinolonesCloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IVNovel Conserved Genotypes Correspond to Antibiotic Resistance Phenotypes of E. coli Clinical IsolatesA mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase IIIncidence of quinolone resistance over the period 1986 to 1998 in veterinary Salmonella isolates from Germany.Genome-wide characterisation of the binding repertoire of small molecule drugs.Insights into the environmental resistance gene pool from the genome sequence of the multidrug-resistant environmental isolate Escherichia coli SMS-3-5.Emergence of a new multidrug-resistant serotype X variant in an epidemic clone of Shigella flexneri.Genomic analysis of the emergence of 20th century epidemic dysentery.Cloning and nucleotide sequences of the topoisomerase IV parC and parE genes of Mycoplasma hominis.Antibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and its optical isomers against type II topoisomerases.Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitroOverexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coliHigh levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen?Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections.Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family EnterobacteriaceaeDetection of ciprofloxacin-resistant Yersinia pestis by fluorogenic PCR using the LightCycler.Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.In vitro activities of 13 fluoroquinolones against Staphylococcus aureus isolates with characterized mutations in gyrA, gyrB, grlA, and norA and against wild-type isolates.Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the fieldIneffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli.Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium.Characterization of fluoroquinolone resistance among veterinary isolates of avian Escherichia coliGenetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.Life-threatening infantile diarrhea from fluoroquinolone-resistant Salmonella enterica typhimurium with mutations in both gyrA and parC.Isolation of Escherichia coli strains with AcrAB-TolC efflux pump-associated intermediate interpretation or resistance to fluoroquinolone, chloramphenicol and aminopenicillin from dogs admitted to a university veterinary hospitalRole of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae.Functional characterization of Brucella melitensis NorMI, an efflux pump belonging to the multidrug and toxic compound extrusion family.Dynamics of quinolone resistance in fecal Escherichia coli of finishing pigs after ciprofloxacin administration.Accumulation of mutations in both gyrB and parE genes is associated with high-level resistance to novobiocin in Staphylococcus aureus.Whole genome sequence analysis of the first Australian OXA-48-producing outbreak-associated Klebsiella pneumoniae isolates: the resistome and in vivo evolution.Alteration of Escherichia coli topoisomerase IV to novobiocin resistance.Plasmid-mediated quinolone resistance in pseudomonas putida isolates from imported shrimp.High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA.Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV.Cloning and nucleotide sequence of the gyrA gene from Campylobacter fetus subsp. fetus ATCC 27374 and characterization of ciprofloxacin-resistant laboratory and clinical isolatesImproved antimicrobial activity of DU-6859a, a new fluoroquinolone, against quinolone-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates with alterations in GyrA and ParC proteinsQuinolone resistance mechanisms among extended-spectrum beta-lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland.
P2860
Q24643546-156E4C18-16F5-4C24-9161-AC6DFE5DC1B2Q28492734-4C9D006F-5A3D-4CF4-B21C-D51EE2FB2F5AQ28534076-F325444D-F344-4CD6-97C7-D8A4343A1461Q30448695-4C7841A1-04EA-4C96-ABE0-2997AC4539B8Q30764312-F2F57CE3-AF11-4564-A819-522A0E52BCDFQ33209914-2BCFED59-0D9F-48F2-9652-CE578469A40FQ33360684-6331A6E2-C12E-4AAF-934B-9F5D0531F0D5Q33627338-494B6021-B402-4431-9D4E-AB4679D8B8B8Q33686643-32B36588-9658-428F-993E-0DDD09C6E911Q33694924-42CBD0D3-87FE-4669-A545-0A1641B6F4CBQ33696363-78F6E259-CB7F-4D0F-8272-32213AF3F0DBQ33696730-9902AE93-FB53-4E1F-A119-C25BF90BB099Q33698034-1AAAE927-0B6F-4B7B-BCB0-DAF91326F94CQ33831154-1FDE382D-A000-40C6-9C4C-295D33C1DF4AQ33836664-FFC9A195-A672-4E3C-9E83-CC781D30EA21Q33959148-E34D2DFA-8A24-4F22-AB32-59E313EDB87AQ33973670-B7904BD8-CDE4-4152-90C5-E004CE1782E1Q33975861-6D45E8B8-60B9-476A-BEAF-045908CC3218Q33976675-FFF00766-B658-4D36-A158-7D04C8C6A559Q33976753-5525D612-2E97-4E0A-99B3-AA226982309EQ33977564-0231F961-5A34-442D-87E8-FB35C4D24C3DQ33978398-0C03017A-967B-4AF9-88E1-1C7EF3F31309Q33979064-82AB0F64-3F07-4675-BB4F-6DB29E465B70Q33979406-DFE3DC05-B80D-41F0-94CC-7E75449E7A32Q33980874-2B2CD24A-AB6A-44B3-9D65-7572ED5CD88FQ33982113-DC81A396-D992-490F-807A-D3A4E8EB307CQ33984368-FFD0CD9F-776F-44B7-81F7-4B7F9477FC28Q34085440-DF11C90B-64B0-4B65-B9DD-4A150232B5B5Q34111663-1CD83316-9278-468D-BF37-74EEEBC7BAFFQ34112138-57FC40C5-506D-4B27-AD9D-7FBAD42FFCB7Q34339497-B12044E3-75E8-4ED7-96A5-211C765B6486Q34446438-81C99103-0FBF-4990-BF38-F407B71BB9BEQ34652593-8C0AD23D-8DE6-4B10-93E7-C966DE7C8C6BQ34735901-CDFD6C99-AB79-4426-8D0A-50B156488C7BQ34738382-DDC2E8C6-F10C-4808-8F58-678C7032CD8CQ35129977-72A2C586-8FC5-43D3-9819-F05314197AB2Q35131579-79636CF6-231A-4638-BC4C-886B8B027037Q35134126-5465112F-BDC8-4A7E-AC57-BCCEF4495739Q35139054-66219BBC-0D70-408E-9597-E2C8582491DEQ35155107-5819FDAD-147A-479E-97F4-83B174FCFC71
P2860
Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.
description
1996 nî lūn-bûn
@nan
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Genetic evidence for a role of ...... esistance in Escherichia coli.
@ast
Genetic evidence for a role of ...... esistance in Escherichia coli.
@en
type
label
Genetic evidence for a role of ...... esistance in Escherichia coli.
@ast
Genetic evidence for a role of ...... esistance in Escherichia coli.
@en
prefLabel
Genetic evidence for a role of ...... esistance in Escherichia coli.
@ast
Genetic evidence for a role of ...... esistance in Escherichia coli.
@en
P2860
P356
P1476
Genetic evidence for a role of ...... resistance in Escherichia coli
@en
P2093
P2860
P304
P356
10.1128/AAC.40.4.879
P407
P577
1996-04-01T00:00:00Z